Results 131 to 140 of about 1,390,389 (383)
Yan Zhang, Min Tang, Qian-Hui Gu, Li-Na Zhou, Min-Bin Chen Department of Oncology & Radiotherapy, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu, 215300, People’s Republic of ChinaCorrespondence: Min-Bin Chen, Department of ...
Zhang Y, Tang M, Gu QH, Zhou LN, Chen MB
doaj
Novel radiation-derived gene blueprint stratifying patients with breast cancer
Background Breast cancer (BC) is a prevalent global malignancy with a high recurrence rate. The effectiveness of predictive, preventive, and personalized treatment strategies is limited by a lack of reliable prognostic biomarkers.
Hao Zhang +4 more
doaj +1 more source
Radiotherapy and Phototherapy [PDF]
n ...
openaire +2 more sources
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková +14 more
wiley +1 more source
Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary survey
Introduction: Radiotherapy education can be very different across Europe, despite the publication of the ESTRO core curricula in 2011. The purpose of the current study is to map the different RO European education systems, to report their perceived ...
Jean-Emmanuel Bibault +12 more
doaj +1 more source
Novel dual single sided silicon strip detector chip for radiotherapy verification [PDF]
A novel dual single sided silicon strip detector (SSSSD) chip was designed to meet clinical requirements in radiotherapy verification. An available design from Micron Semiconductor Ltd.
Abou-Haïdara, Z. +10 more
core
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim +11 more
wiley +1 more source
Molecular Pharmacological Interventions for Endometrial Cancer: A Comprehensive Review
Wei Qin,1,* Yazhou Qi,2,* Qianwen Li,2,* Bei Wang,2,* Jingmiao Wang,3 Xueke Ge,3 Yanhong Li,4 Xinyue Zhang,4 Kuan Liu4 1Internal Medicine of Integrated Chinese and Western Medicine, Affiliated Hospital of Hebei University,
Qin W +8 more
doaj
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez +5 more
wiley +1 more source

